RxDoctor Payments Data

Arthur Badikian, MD

Psychiatry · Harrison, NYNPI 1134255946

Payments from drug & device makers

$2,100in general payments, 2019–2025

Across 10 payments — averaging $210.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Johnson & Johnson$250
  • Neuronetics, Inc.$230
  • Otsuka America Pharmaceutical, Inc.$125
  • Teva Pharmaceuticals USA, Inc.$125
  • AbbVie$11

What the payments were for

  • Speaking & faculty fees$1,32063%
  • Travel & lodging$392%
  • Food & beverage$74135%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,100 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$136,182
Medicare patients
162
Services billed
1,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide40$26,021
RexultiBrexpiprazole16$22,207
Escitalopram Oxalate466$8,185
VyvanseLisdexamfetamine Dimesylate14$5,331
Bupropion XlBupropion Hcl162$5,279
Desvenlafaxine Succinate ErDesvenlafaxine Succinate55$3,262
Quetiapine Fumarate151$3,159
Duloxetine Hcl86$2,882
Venlafaxine Hcl ErVenlafaxine Hcl129$2,274
Methylphenidate ErMethylphenidate Hcl15$2,163
Alprazolam169$1,830
Clonazepam197$1,812
Trazodone Hcl174$1,773
Methylphenidate Hcl30$1,305
Sertraline Hcl84$1,129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$1,359$31,35254 claims
Otsuka America Pharmaceutical, Inc.Rexulti$125$22,20716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Harrison

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →